{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T19:00:42Z","timestamp":1783796442072,"version":"3.55.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.puhe.2021.05.028","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T03:17:35Z","timestamp":1623035855000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["COVID-19, corticosteroids and public health: a reappraisal"],"prefix":"10.1016","volume":"197","author":[{"given":"M.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Br\u00e1bek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2021.05.028_bib1","series-title":"Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19","year":"2020"},{"key":"10.1016\/j.puhe.2021.05.028_bib2","first-page":"693","article-title":"Dexamethasone in hospitalized patients with covid-19 - preliminary report","volume":"364","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/d41586-020-01824-5","article-title":"Coronavirus breakthrough: dexamethasone is the first drug shown to save lives","volume":"582","author":"Ledford","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.puhe.2021.05.028_bib4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.2020.16747","article-title":"Editorial. Corticosteroids in COVID-19 ARDS: evidence and hope during the pandemic","volume":"324","author":"Prescott","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2021.05.028_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/d41586-020-02416-z","article-title":"How we accelerated clinical trials in the age of COVID-19","volume":"584","author":"Mather","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.puhe.2021.05.028_bib6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19. A meta-analysis","volume":"324","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2021.05.028_bib7","series-title":"Corticosteroids for COVID-19. World Health Organisation","year":"2020"},{"key":"10.1016\/j.puhe.2021.05.028_bib8","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/jama.2020.12698","article-title":"Estimating risk ratios and risk differences: alternatives to Odds Ratios","volume":"324","author":"Holmberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2021.05.028_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00134-017-4859-0","article-title":"Should we rely on trials with disease- rather than patient-oriented endpoints?","volume":"44","author":"de Grooth","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib10","series-title":"Statistics with confidence","article-title":"Proportions and their differences","author":"Newcombe","year":"2000"},{"key":"10.1016\/j.puhe.2021.05.028_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.369.6500.124","article-title":"One U.K. trial is transforming COVID-19 treatment. Why haven't others delivered more results?","volume":"369","author":"Kupferschmidt","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.puhe.2021.05.028_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMe2025674","article-title":"The RECOVERY platform","volume":"384","author":"Normand","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib13","first-page":"647","article-title":"Ventilator-induced lung injury and sepsis: two sides of the same coin?","volume":"77","author":"Villar","year":"2011","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.puhe.2021.05.028_bib14","first-page":"166","article-title":"Pre-treatment with dexamethasone attenuates experimental ventilator-induced lung injury","volume":"42","author":"Reis","year":"2016","journal-title":"J\u00a0Bras Pneumol"},{"key":"10.1016\/j.puhe.2021.05.028_bib15","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1164\/ajrccm.157.6.9709092","article-title":"Multiple system organ failure: is mechanical ventilation a contributing factor?","volume":"157","author":"Slutsky","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib16","first-page":"382","article-title":"Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature","volume":"63","author":"Halbertsma","year":"2005","journal-title":"Neth J Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fped.2016.00079","article-title":"Argument against the routine use of steroids for pediatric acute respiratory distress syndrome","volume":"4","author":"Hartmann","year":"2016","journal-title":"Front Pediatr"},{"key":"10.1016\/j.puhe.2021.05.028_bib18","doi-asserted-by":"crossref","first-page":"17654","DOI":"10.1038\/srep17654","article-title":"The effectiveness of corticosteroids on mortality in patients with acute respiratory distress syndrome or acute lung injury: a secondary analysis","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.puhe.2021.05.028_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40560-018-0321-9","article-title":"Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS","volume":"6","author":"Meduri","year":"2018","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.puhe.2021.05.028_bib20","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMra1208707","article-title":"Ventilator-induced lung injury","volume":"369","author":"Slutsky","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.12688\/f1000research.20576.1","article-title":"Emerging concepts in ventilation-induced lung injury","volume":"9","author":"Madahar","year":"2020","journal-title":"F1000Research"},{"key":"10.1016\/j.puhe.2021.05.028_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/anae.12085","article-title":"Inflammatory mechanisms of ventilator-induced lung injury: a time to stop and think?","volume":"68","author":"Wilson","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1016\/j.puhe.2021.05.028_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/bja\/aeh031","article-title":"Protective ventilation of patients with acute respiratory distress syndrome","volume":"92","author":"Moloney","year":"2004","journal-title":"BJA"},{"key":"10.1016\/j.puhe.2021.05.028_bib24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.chest.2016.07.019","article-title":"Biotrauma and ventilator induced lung injury: clinical implications","volume":"150","author":"Curley","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.puhe.2021.05.028_bib25","article-title":"Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019","volume":"2","author":"Villar","year":"2020","journal-title":"Crit Care Expl"},{"key":"10.1016\/j.puhe.2021.05.028_bib26","first-page":"13","article-title":"The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis","volume":"81","author":"Yang","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.puhe.2021.05.028_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13054-019-2395-8","article-title":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis","volume":"23","author":"Ni","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.puhe.2021.05.028_bib28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome","volume":"197","author":"Arabi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib29","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1038\/srep07176","article-title":"Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon","volume":"4","author":"Thomas","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.puhe.2021.05.028_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","article-title":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients","volume":"31","author":"Lee","year":"2004","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.puhe.2021.05.028_bib31","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/rccm.201712-2371ED","article-title":"Systemic corticosteroid therapy may delay viral clearance in patients with Middle East Respiratory Syndrome coronavirus infection","volume":"197","author":"Hui","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib32","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41375-020-0848-3","article-title":"Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis","volume":"34","author":"Li","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.puhe.2021.05.028_bib33","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1172\/JCI140617","article-title":"Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome","volume":"130","author":"Liu","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.puhe.2021.05.028_bib34","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1172\/JCI143331","article-title":"Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome","volume":"130","author":"Matthay","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.puhe.2021.05.028_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2302\/kjm.2020-0007-LE","article-title":"COVID-19: stay cool toward corticosteroids","volume":"69","author":"Fujishima","year":"2020","journal-title":"Keio J Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2021.05.028_bib37","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/jmv.26483","article-title":"Are the steroids a blanket solution for COVID-19? A systematic review and meta-analysis","volume":"93","author":"Sarkar","year":"2021","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.puhe.2021.05.028_bib38","first-page":"416","article-title":"Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)","volume":"212","author":"Zha","year":"2020","journal-title":"MJA"},{"key":"10.1016\/j.puhe.2021.05.028_bib39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/CCM.0000000000001616","article-title":"Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia","volume":"44","author":"Cao","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib40","first-page":"274","article-title":"The new role of steroids in viral infections","volume":"4","author":"Gola","year":"2017","journal-title":"Front Clin Drug Res - Anti-Infectives"},{"key":"10.1016\/j.puhe.2021.05.028_bib41","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1002\/anie.202015639","article-title":"Molecular simulations suggest vitamins, retinoids and steroids as ligands of the free fatty acid pocket of the SARS-CoV-2 Spike protein","volume":"60","author":"Shoemark","year":"2021","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.puhe.2021.05.028_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cei.13523","article-title":"Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage","volume":"202","author":"Amor","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.puhe.2021.05.028_bib43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.puhe.2021.05.028_bib44","article-title":"An \u2018uncoordinated\u2019 immune response may explain why COVID-19 strikes some hard, particularly the elderly","author":"Cohen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.puhe.2021.05.028_bib45","series-title":"Charting a coronavirus infection","author":"Wu","year":"2020"},{"key":"10.1016\/j.puhe.2021.05.028_bib46","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.369.6511.1550","article-title":"Flawed interferon response spurs severe illness","volume":"369","author":"Wadman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.puhe.2021.05.028_bib47","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and Type III interferons \u2013 induction, signaling, evasion, and application to combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.puhe.2021.05.028_bib48","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/MCB.00146-10","article-title":"The type I interferon signaling pathway is a target for glucocorticoid inhibition","volume":"30","author":"Flammer","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.puhe.2021.05.028_bib49","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1038\/srep07176","article-title":"Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon","volume":"4","author":"Thomas","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.puhe.2021.05.028_bib50","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00134-020-06086-3","article-title":"Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung","volume":"46","author":"Jalkanen","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib51","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib52","series-title":"Virus variants likely evolved inside people with weak immune systems","author":"Mandavilli","year":"2021"},{"key":"10.1016\/j.puhe.2021.05.028_bib53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jama.2020.27124","article-title":"Genetic variants of SARS-CoV-2\u2014what do they mean?","volume":"325","author":"Lauring","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2021.05.028_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","author":"Kemp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.puhe.2021.05.028_bib55","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/21505594.2021.1877066","article-title":"Editorial. COVID-19 evolution during the pandemic \u2013 implications of new SARS-CoV-2 variants on disease control and public health policies","volume":"12","author":"van Oosterhout","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.puhe.2021.05.028_bib56","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.puhe.2021.05.028_bib57","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.chom.2021.02.010","article-title":"The great escape? SARS-CoV-2 variants evading neutralizing responses","volume":"29","author":"Pr\u00e9vost","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.puhe.2021.05.028_bib58","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(21)00298-1","article-title":"Understanding variants of SARS-CoV-2","volume":"397","author":"Burki","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.puhe.2021.05.028_bib59","article-title":"The coronavirus variants don't seem to be highly variable so far","volume":"32","author":"Cooper","year":"2021","journal-title":"Sci Am"},{"key":"10.1016\/j.puhe.2021.05.028_bib60","article-title":"New SARS-CoV-2 Variants \u2014 clinical, public health, and vaccine implications","author":"Karim","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib61","series-title":"Breakthrough drug for Covid-19 may be risky for mild cases","author":"Rabin","year":"2020"},{"key":"10.1016\/j.puhe.2021.05.028_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/CMI.1000207","article-title":"A\u00a0recurrent question from a primary care physician: how should I treat my COVID-19 patients at home?","volume":"5","author":"Perico","year":"2020","journal-title":"Clin Med Invest"},{"key":"10.1016\/j.puhe.2021.05.028_bib63","series-title":"Dexamethasone demand soars after positive Covid-19 Study","author":"Hopkins","year":"2020"},{"key":"10.1016\/j.puhe.2021.05.028_bib64","series-title":"US hospital orders soar for Covid-19 steroid treatment","author":"Kuchler","year":"2020"},{"key":"10.1016\/j.puhe.2021.05.028_bib65","article-title":"Covid-19: demand for dexamethasone surges as RECOVERY trial publishes preprint","volume":"369","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.puhe.2021.05.028_bib66","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620942131","article-title":"Worrying situation regarding the use of dexamethasone for COVID-19","volume":"14","author":"Lim","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.puhe.2021.05.028_bib67","article-title":"With dexamethasone's sudden COVID-19 blessing, U.S. steroid supplies plummet","author":"Kansteiner","year":"2020","journal-title":"Fierce Pharma"},{"key":"10.1016\/j.puhe.2021.05.028_bib68","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19. The CoDEX Randomized Clinical Trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2021.05.028_bib69","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2021.05.028_bib70","article-title":"Covid-19: risk factors for severe disease and death","volume":"368","author":"Jordan","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.puhe.2021.05.028_bib71","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1473-3099(20)30706-4","article-title":"Curing COVID-19","volume":"20","author":"Editorial","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.puhe.2021.05.028_bib72","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.puhe.2021.05.028_bib73","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.368.6489.356","article-title":"A\u00a0rampage through the body","volume":"368","author":"Wadman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.puhe.2021.05.028_bib74","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.puhe.2021.05.028_bib75","first-page":"3027","article-title":"Raloxifene and Bazedoxifene could be promising candidates for preventing the COVID-19 related cytokine storm, ARDS and mortality","volume":"34","author":"Smetana","year":"2020","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.puhe.2021.05.028_bib76","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2021.05.028_bib77","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41590-020-0779-1","article-title":"The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge","volume":"21","author":"Buszko","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.puhe.2021.05.028_bib78","article-title":"Kinins and Cytokines in COVID-19: a comprehensive pathophysiological approach","author":"van de Veerdonk","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.puhe.2021.05.028_bib79","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59177","article-title":"A\u00a0mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm","volume":"9","author":"Garvin","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.puhe.2021.05.028_bib80","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57555","article-title":"Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome","volume":"9","author":"van de Veerdonk","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.puhe.2021.05.028_bib81","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1111\/jth.15050","article-title":"Is the COVID-19 thrombotic catastrophe complement-connected?","volume":"18","author":"Conway","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.puhe.2021.05.028_bib82","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012642","article-title":"Rationale for targeting complement in COVID-19","volume":"12","author":"Polycarpou","year":"2020","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib83","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s41030-020-00118-5","article-title":"A\u00a0Review: does complement or the contact system have a role in protection or pathogenesis of COVID-19?","volume":"6","author":"Maglakelidze","year":"2020","journal-title":"Pulm Ther"},{"key":"10.1016\/j.puhe.2021.05.028_bib84","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a target in COVID-19?","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.puhe.2021.05.028_bib85","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.4049\/jimmunol.2000644","article-title":"COVID-19: complement, coagulation, and collateral damage","volume":"205","author":"Lo","year":"2020","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.puhe.2021.05.028_bib86","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","volume":"69","author":"Iba","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.puhe.2021.05.028_bib87","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/rth2.12349","article-title":"The contact activation system as a potential therapeutic target in patients with COVID-19","volume":"4","author":"Shatzel","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.puhe.2021.05.028_bib88","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.puhe.2021.05.028_bib89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.puhe.2021.05.028_bib90","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib91","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1182\/blood.2020007951","article-title":"NET-thrombosis axis in COVID-19","volume":"136","author":"Hidalgo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.puhe.2021.05.028_bib92","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2021.05.028_bib93","first-page":"1","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","author":"Bonaventura","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.puhe.2021.05.028_bib94","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2213-2600(18)30279-0","article-title":"Negative trials in critical care: why most research is probably wrong","volume":"6","author":"Laffey","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"Suppl 1","key":"10.1016\/j.puhe.2021.05.028_bib95","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.21037\/jtd.2019.10.36","article-title":"Time to stop randomized and large pragmatic trials for intensive care medicine syndromes: the case of sepsis and acute respiratory distress syndrome","volume":"12","author":"Girbes","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.puhe.2021.05.028_bib96","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13362","article-title":"Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis","volume":"50","author":"Figliozzi","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.puhe.2021.05.028_bib97","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s13054-020-03360-0","article-title":"Corticosteroids in severe COVID-19: a critical view of the evidence","volume":"24","author":"De Backer","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.puhe.2021.05.028_bib98","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jama.2020.10178","article-title":"Making decisions in a COVID-19 world","volume":"324","author":"Fischoff","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2021.05.028_bib99","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2021.05.028_bib100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(20)32021-3","article-title":"Remdesivir and COVID-19","volume":"396","author":"Glaus","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2021.05.028_bib101","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S2214-109X(20)30365-X","article-title":"Clinical trials of disease stages in COVID 19: complicated and often misinterpreted","volume":"8","author":"Park","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.puhe.2021.05.028_bib102","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S2213-2600(20)30070-9","article-title":"Toning down the 2019-nCoV media hype\u2014and restoring hope","volume":"8","author":"Ippolito","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.puhe.2021.05.028_bib103","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ije\/30.3.442","article-title":"Commentary: the prevention paradox in lay epidemiology--Rose revisited","volume":"30","author":"Hunt","year":"2001","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.puhe.2021.05.028_bib104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ije\/14.1.32","article-title":"Sick individuals and sick populations","volume":"14","author":"Rose","year":"1985","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.puhe.2021.05.028_bib105","article-title":"Dexamethasone in the management of covid-19","volume":"370","author":"Editorial","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.puhe.2021.05.028_bib106","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jama.2020.12535","article-title":"Communicating science in the time of a pandemic","volume":"324","author":"Saitz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2021.05.028_bib107","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(20)31954-1","article-title":"COVID-19: a stress test for trust in science","volume":"396","year":"2020","journal-title":"Lancet"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350621002146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350621002146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:35:32Z","timestamp":1758501332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350621002146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":107,"alternative-id":["S0033350621002146"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2021.05.028","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19, corticosteroids and public health: a reappraisal","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2021.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}